BlackRock Fund Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$66.2M	Buy	1,490,258 +167,744	+13%	+$5.9M	0.01%	1494
2016 Q3	$47.7M	Buy	1,322,514 +47,980	+4%	+$1.03M	0.01%	1610
2016 Q2	$17.5M	Buy	1,274,534 +75,613	+6%	+$1.11M	﹤0.01%	2100
2016 Q1	$23M	Buy	1,198,921 +44,935	+4%	+$951K	0.01%	1901
2015 Q4	$40.4M	Sell	1,153,986 -81,894	-7%	-$5.28M	0.01%	1623
2015 Q3	$114M	Buy	1,235,880 +196,771	+19%	+$17M	0.03%	807
2015 Q2	$91.3M	Sell	1,039,109 -27,131	-3%	-$2.32M	0.02%	1069
2015 Q1	$79.1M	Buy	1,066,240 +26,579	+3%	+$1.88M	0.02%	1189
2014 Q4	$58.2M	Buy	1,039,661 +80,670	+8%	+$4.24M	0.01%	1358
2014 Q3	$43.5M	Buy	958,991 +899	+0.1%	+$37.6K	0.01%	1444
2014 Q2	$39.7M	Buy	958,092 +95,785	+11%	+$4.93M	0.01%	1554
2014 Q1	$59.7M	Buy	862,307 +32,653	+4%	+$2.4M	0.02%	1285
2013 Q4	$50M	Buy	829,654 +89,308	+12%	+$4.86M	0.02%	1395
2013 Q3	$45M	Buy	740,346 +183,389	+33%	+$13M	0.02%	1420
2013 Q2	$37.3M	Buy	+556,957	New	+$25M	0.01%	1441